Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of relaxation of muscle (GO:1901077) | 8.02867998 |
2 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.28735544 |
3 | actin filament-based movement (GO:0030048) | 5.72114483 |
4 | response to inactivity (GO:0014854) | 5.58163560 |
5 | response to muscle activity (GO:0014850) | 5.37350577 |
6 | regulation of actin filament-based movement (GO:1903115) | 5.08654033 |
7 | skeletal muscle fiber development (GO:0048741) | 4.97689719 |
8 | cardiac myofibril assembly (GO:0055003) | 4.87488567 |
9 | myotube cell development (GO:0014904) | 4.79910695 |
10 | muscle contraction (GO:0006936) | 4.60796019 |
11 | neuronal action potential propagation (GO:0019227) | 4.57572264 |
12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.50260302 |
13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.49827335 |
14 | cardiac muscle hypertrophy (GO:0003300) | 4.34858314 |
15 | skeletal muscle adaptation (GO:0043501) | 4.27499324 |
16 | muscle fiber development (GO:0048747) | 4.25159559 |
17 | striated muscle hypertrophy (GO:0014897) | 4.18795934 |
18 | muscle system process (GO:0003012) | 4.16480605 |
19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.16129699 |
20 | actomyosin structure organization (GO:0031032) | 4.14637754 |
21 | synaptic vesicle maturation (GO:0016188) | 4.05947304 |
22 | regulation of striated muscle contraction (GO:0006942) | 3.89885131 |
23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.89603501 |
24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88670530 |
25 | locomotory exploration behavior (GO:0035641) | 3.82698937 |
26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.80867751 |
27 | * glycogen biosynthetic process (GO:0005978) | 3.79347903 |
28 | * glucan biosynthetic process (GO:0009250) | 3.79347903 |
29 | synaptic vesicle exocytosis (GO:0016079) | 3.77606222 |
30 | vocalization behavior (GO:0071625) | 3.76098863 |
31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.73826456 |
32 | muscle hypertrophy (GO:0014896) | 3.71990283 |
33 | skeletal muscle tissue development (GO:0007519) | 3.70835826 |
34 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.66116571 |
35 | adult heart development (GO:0007512) | 3.63690990 |
36 | glutamate secretion (GO:0014047) | 3.62848297 |
37 | regulation of sequestering of triglyceride (GO:0010889) | 3.61178926 |
38 | heart process (GO:0003015) | 3.58603950 |
39 | heart contraction (GO:0060047) | 3.58603950 |
40 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.57540799 |
41 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.57540799 |
42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.55513026 |
43 | cellular polysaccharide catabolic process (GO:0044247) | 3.54448159 |
44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53824893 |
45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.50738041 |
46 | striated muscle adaptation (GO:0014888) | 3.49227788 |
47 | regulation of cell communication by electrical coupling (GO:0010649) | 3.48473011 |
48 | ubiquinone biosynthetic process (GO:0006744) | 3.46741102 |
49 | 2-oxoglutarate metabolic process (GO:0006103) | 3.44312345 |
50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.41369435 |
51 | regulation of skeletal muscle contraction (GO:0014819) | 3.40705774 |
52 | NADH metabolic process (GO:0006734) | 3.37520080 |
53 | muscle filament sliding (GO:0030049) | 3.37290031 |
54 | actin-myosin filament sliding (GO:0033275) | 3.37290031 |
55 | muscle tissue morphogenesis (GO:0060415) | 3.37123459 |
56 | muscle cell cellular homeostasis (GO:0046716) | 3.34958708 |
57 | regulation of synaptic vesicle transport (GO:1902803) | 3.33460200 |
58 | striated muscle cell development (GO:0055002) | 3.32412212 |
59 | plasma membrane repair (GO:0001778) | 3.32265970 |
60 | cardiac muscle cell development (GO:0055013) | 3.31261206 |
61 | regulation of synapse structural plasticity (GO:0051823) | 3.27640101 |
62 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.25895074 |
63 | succinate metabolic process (GO:0006105) | 3.25484096 |
64 | polysaccharide catabolic process (GO:0000272) | 3.23855820 |
65 | relaxation of muscle (GO:0090075) | 3.22277743 |
66 | neurotransmitter secretion (GO:0007269) | 3.21815781 |
67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.21776228 |
68 | response to activity (GO:0014823) | 3.20341754 |
69 | activation of protein kinase A activity (GO:0034199) | 3.17875958 |
70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17589081 |
71 | protein localization to synapse (GO:0035418) | 3.16494488 |
72 | response to caffeine (GO:0031000) | 3.16299843 |
73 | carnitine shuttle (GO:0006853) | 3.15546353 |
74 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.15180862 |
75 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.14518002 |
76 | gamma-aminobutyric acid transport (GO:0015812) | 3.14364887 |
77 | membrane depolarization during action potential (GO:0086010) | 3.13940673 |
78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.12481697 |
79 | muscle structure development (GO:0061061) | 3.12205452 |
80 | detection of calcium ion (GO:0005513) | 3.11422226 |
81 | skeletal muscle contraction (GO:0003009) | 3.10538503 |
82 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.09937101 |
83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.09825393 |
84 | muscle organ development (GO:0007517) | 3.09006577 |
85 | neuron cell-cell adhesion (GO:0007158) | 3.08949959 |
86 | regulation of membrane repolarization (GO:0060306) | 3.07620881 |
87 | carnitine transmembrane transport (GO:1902603) | 3.06939828 |
88 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05816267 |
89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.05671494 |
90 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.05671494 |
91 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.04805529 |
92 | ubiquinone metabolic process (GO:0006743) | 3.04492749 |
93 | mitochondrial genome maintenance (GO:0000002) | 3.03124336 |
94 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.01602530 |
95 | skeletal muscle tissue regeneration (GO:0043403) | 3.00798209 |
96 | relaxation of cardiac muscle (GO:0055119) | 2.98844320 |
97 | cardiac cell development (GO:0055006) | 2.97531539 |
98 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.96887837 |
99 | proline transport (GO:0015824) | 2.96745564 |
100 | regulation of ATP catabolic process (GO:1903289) | 2.96213551 |
101 | regulation of ATPase activity (GO:0043462) | 2.96213551 |
102 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.93532588 |
103 | * glycogen metabolic process (GO:0005977) | 2.92818343 |
104 | positive regulation of myoblast differentiation (GO:0045663) | 2.92391548 |
105 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.91038504 |
106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.90937738 |
107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90541995 |
108 | regulation of sarcomere organization (GO:0060297) | 2.90304579 |
109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.89846142 |
110 | cellular potassium ion homeostasis (GO:0030007) | 2.89773260 |
111 | glutamate receptor signaling pathway (GO:0007215) | 2.88817444 |
112 | cardiac muscle adaptation (GO:0014887) | 2.86520797 |
113 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.86520797 |
114 | muscle hypertrophy in response to stress (GO:0003299) | 2.86520797 |
115 | aspartate family amino acid catabolic process (GO:0009068) | 2.86325729 |
116 | exploration behavior (GO:0035640) | 2.85856316 |
117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.85549979 |
118 | striated muscle contraction (GO:0006941) | 2.85120759 |
119 | regulation of the force of heart contraction (GO:0002026) | 2.84536373 |
120 | neuron-neuron synaptic transmission (GO:0007270) | 2.84276455 |
121 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.83817120 |
122 | cell communication by electrical coupling (GO:0010644) | 2.82555701 |
123 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.82083496 |
124 | layer formation in cerebral cortex (GO:0021819) | 2.81196764 |
125 | potassium ion import (GO:0010107) | 2.81086700 |
126 | synaptic transmission, glutamatergic (GO:0035249) | 2.79366122 |
127 | fatty acid transmembrane transport (GO:1902001) | 2.78578289 |
128 | actin-mediated cell contraction (GO:0070252) | 2.78043253 |
129 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.77345619 |
130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74409822 |
131 | long-term memory (GO:0007616) | 2.72424063 |
132 | neurotransmitter transport (GO:0006836) | 2.71971594 |
133 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68542703 |
134 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.66713748 |
135 | cell communication involved in cardiac conduction (GO:0086065) | 2.65291455 |
136 | glycogen catabolic process (GO:0005980) | 2.65044887 |
137 | neuromuscular process controlling posture (GO:0050884) | 2.65025704 |
138 | sarcomere organization (GO:0045214) | 2.62949095 |
139 | cardiac muscle contraction (GO:0060048) | 2.62454029 |
140 | myofibril assembly (GO:0030239) | 2.60832271 |
141 | dendritic spine morphogenesis (GO:0060997) | 2.57659997 |
142 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.57650188 |
143 | regulation of cation channel activity (GO:2001257) | 2.57244009 |
144 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56940611 |
145 | glycine transport (GO:0015816) | 2.56883521 |
146 | creatine metabolic process (GO:0006600) | 2.56681750 |
147 | membrane depolarization (GO:0051899) | 2.55486415 |
148 | neuromuscular synaptic transmission (GO:0007274) | 2.55219963 |
149 | neuron recognition (GO:0008038) | 2.54416598 |
150 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.54391161 |
151 | transmission of nerve impulse (GO:0019226) | 2.53978950 |
152 | regulation of cofactor metabolic process (GO:0051193) | 2.53277745 |
153 | regulation of coenzyme metabolic process (GO:0051196) | 2.53277745 |
154 | vesicle transport along microtubule (GO:0047496) | 2.52935100 |
155 | regulation of neurotransmitter levels (GO:0001505) | 2.52192832 |
156 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.49343403 |
157 | positive regulation of potassium ion transport (GO:0043268) | 2.48100558 |
158 | positive regulation of cation channel activity (GO:2001259) | 2.47891236 |
159 | sodium ion export (GO:0071436) | 2.46865111 |
160 | regulation of transmembrane transporter activity (GO:0022898) | 2.46520991 |
161 | glucan catabolic process (GO:0009251) | 2.46047497 |
162 | behavioral response to cocaine (GO:0048148) | 2.44487736 |
163 | tricarboxylic acid cycle (GO:0006099) | 2.44052487 |
164 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.43848420 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.91274843 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84933783 |
3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.56294206 |
4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.84851386 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82225203 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68363337 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66866581 |
8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.49902129 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.36206897 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.36206897 |
11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.29837491 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29196369 |
13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24210236 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19756032 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18489560 |
16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16533409 |
17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16049472 |
18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14459608 |
19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13130407 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10840651 |
21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04994346 |
22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02681327 |
23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.01517782 |
24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.98817921 |
25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93333387 |
26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91304972 |
27 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88095419 |
28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.82086990 |
29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81653140 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76649824 |
31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.75289084 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65814242 |
33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65494508 |
34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64249779 |
35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56907899 |
36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55939113 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54015818 |
38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52298985 |
39 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51219859 |
40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49427205 |
41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47032990 |
42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46230884 |
43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44731436 |
44 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44643663 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41003559 |
46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36652058 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36436176 |
48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35889248 |
49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35889248 |
50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35760644 |
51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34818939 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33146468 |
53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32682656 |
54 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32316265 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31971563 |
56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31318393 |
57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29708500 |
58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29574071 |
59 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29004308 |
60 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27830596 |
61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27818085 |
62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27196327 |
63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26305346 |
64 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25515621 |
65 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.24751234 |
66 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24751234 |
67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24485891 |
68 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.22340406 |
69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20757934 |
70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.20676444 |
71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19991104 |
72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19666444 |
73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18864824 |
74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18420453 |
75 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18168186 |
76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17376952 |
77 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16976420 |
78 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.16173015 |
79 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.14565312 |
80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13529478 |
81 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13443311 |
82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12405192 |
83 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.11866133 |
84 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11577168 |
85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11479267 |
86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11368063 |
87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10834675 |
88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10834675 |
89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10741237 |
90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10466612 |
91 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09758307 |
92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09432388 |
93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08781052 |
94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08611469 |
95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07583631 |
96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06510648 |
97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05793820 |
98 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04826634 |
99 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03768422 |
100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03158522 |
101 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02816345 |
102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02543615 |
103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01940697 |
104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01654438 |
105 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01551796 |
106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01335055 |
107 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01030633 |
108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99748651 |
109 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99676912 |
110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99267788 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99228932 |
112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99007994 |
113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98915083 |
114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98476148 |
115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98450108 |
116 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98309783 |
117 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97748588 |
118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97457061 |
119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97185232 |
120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96753964 |
121 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.96288868 |
122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95931881 |
123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95836347 |
124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95836347 |
125 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95693907 |
126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95546325 |
127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95429472 |
128 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94698167 |
129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94206023 |
130 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94005556 |
131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93741765 |
132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93403521 |
133 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92949022 |
134 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91340579 |
135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91233893 |
136 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91109627 |
137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90500580 |
138 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89417393 |
139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88721624 |
140 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.88161185 |
141 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88041225 |
142 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86946455 |
143 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86432262 |
144 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85320288 |
145 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.85253210 |
146 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84387040 |
147 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83888429 |
148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83137728 |
149 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81437437 |
150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81177757 |
151 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80887711 |
152 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79875033 |
153 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79839572 |
154 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79749324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.57622335 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.66635557 |
3 | MP0004145_abnormal_muscle_electrophysio | 3.65365631 |
4 | MP0003646_muscle_fatigue | 3.58652060 |
5 | MP0004270_analgesia | 3.27697493 |
6 | MP0000751_myopathy | 3.26759505 |
7 | MP0003880_abnormal_central_pattern | 3.15229786 |
8 | MP0003635_abnormal_synaptic_transmissio | 2.94906683 |
9 | MP0000749_muscle_degeneration | 2.67460442 |
10 | MP0009745_abnormal_behavioral_response | 2.48624078 |
11 | MP0004036_abnormal_muscle_relaxation | 2.45738440 |
12 | MP0002822_catalepsy | 2.42131134 |
13 | MP0004130_abnormal_muscle_cell | 2.32613437 |
14 | * MP0002064_seizures | 2.31928915 |
15 | * MP0002063_abnormal_learning/memory/cond | 2.26728908 |
16 | * MP0009046_muscle_twitch | 2.25200136 |
17 | MP0001968_abnormal_touch/_nociception | 2.05725391 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.03083222 |
19 | * MP0002272_abnormal_nervous_system | 1.99717006 |
20 | * MP0000747_muscle_weakness | 1.97236377 |
21 | MP0004215_abnormal_myocardial_fiber | 1.89062041 |
22 | MP0002572_abnormal_emotion/affect_behav | 1.86221956 |
23 | MP0000372_irregular_coat_pigmentation | 1.84156169 |
24 | MP0005620_abnormal_muscle_contractility | 1.83282318 |
25 | MP0001440_abnormal_grooming_behavior | 1.81310381 |
26 | * MP0001486_abnormal_startle_reflex | 1.79183439 |
27 | MP0002106_abnormal_muscle_physiology | 1.77502564 |
28 | MP0002735_abnormal_chemical_nociception | 1.74648019 |
29 | MP0001501_abnormal_sleep_pattern | 1.71823676 |
30 | MP0005451_abnormal_body_composition | 1.66059481 |
31 | MP0002909_abnormal_adrenal_gland | 1.65737572 |
32 | MP0009780_abnormal_chondrocyte_physiolo | 1.65123216 |
33 | MP0004084_abnormal_cardiac_muscle | 1.64681453 |
34 | MP0002269_muscular_atrophy | 1.59884738 |
35 | MP0000759_abnormal_skeletal_muscle | 1.59438696 |
36 | MP0002067_abnormal_sensory_capabilities | 1.58422335 |
37 | MP0004087_abnormal_muscle_fiber | 1.57891221 |
38 | MP0004147_increased_porphyrin_level | 1.57414120 |
39 | MP0002736_abnormal_nociception_after | 1.57104004 |
40 | MP0005266_abnormal_metabolism | 1.55675374 |
41 | MP0008569_lethality_at_weaning | 1.50733786 |
42 | MP0004233_abnormal_muscle_weight | 1.50245806 |
43 | MP0005423_abnormal_somatic_nervous | 1.48910175 |
44 | MP0005369_muscle_phenotype | 1.47588442 |
45 | MP0003329_amyloid_beta_deposits | 1.46676478 |
46 | MP0002733_abnormal_thermal_nociception | 1.44596269 |
47 | MP0004858_abnormal_nervous_system | 1.43409591 |
48 | MP0001970_abnormal_pain_threshold | 1.42829568 |
49 | MP0004484_altered_response_of | 1.41445729 |
50 | MP0004924_abnormal_behavior | 1.40277761 |
51 | MP0005386_behavior/neurological_phenoty | 1.40277761 |
52 | MP0005330_cardiomyopathy | 1.38974197 |
53 | MP0000013_abnormal_adipose_tissue | 1.34393205 |
54 | MP0002127_abnormal_cardiovascular_syste | 1.33748079 |
55 | MP0004043_abnormal_pH_regulation | 1.32784107 |
56 | MP0000733_abnormal_muscle_development | 1.31257045 |
57 | MP0008877_abnormal_DNA_methylation | 1.28261249 |
58 | MP0010630_abnormal_cardiac_muscle | 1.25869214 |
59 | MP0005646_abnormal_pituitary_gland | 1.24142911 |
60 | MP0004085_abnormal_heartbeat | 1.22610113 |
61 | MP0003137_abnormal_impulse_conducting | 1.22148679 |
62 | MP0004142_abnormal_muscle_tone | 1.20491867 |
63 | MP0004885_abnormal_endolymph | 1.20349938 |
64 | MP0001661_extended_life_span | 1.19753053 |
65 | MP0006276_abnormal_autonomic_nervous | 1.18918674 |
66 | MP0002972_abnormal_cardiac_muscle | 1.18046100 |
67 | * MP0002066_abnormal_motor_capabilities/c | 1.17684701 |
68 | MP0005535_abnormal_body_temperature | 1.16053117 |
69 | MP0003879_abnormal_hair_cell | 1.15696277 |
70 | MP0003950_abnormal_plasma_membrane | 1.14010806 |
71 | MP0002184_abnormal_innervation | 1.13134981 |
72 | MP0002557_abnormal_social/conspecific_i | 1.12466698 |
73 | MP0000750_abnormal_muscle_regeneration | 1.10845452 |
74 | MP0005670_abnormal_white_adipose | 1.10751927 |
75 | MP0003633_abnormal_nervous_system | 1.09926907 |
76 | MP0000955_abnormal_spinal_cord | 1.07983245 |
77 | MP0004510_myositis | 1.06616449 |
78 | MP0001984_abnormal_olfaction | 1.03688375 |
79 | * MP0004811_abnormal_neuron_physiology | 1.03190821 |
80 | MP0002876_abnormal_thyroid_physiology | 1.02159944 |
81 | MP0006036_abnormal_mitochondrial_physio | 1.01731657 |
82 | MP0002332_abnormal_exercise_endurance | 1.00885880 |
83 | MP0003690_abnormal_glial_cell | 0.99788912 |
84 | * MP0002882_abnormal_neuron_morphology | 0.98744481 |
85 | * MP0002229_neurodegeneration | 0.94766513 |
86 | MP0000778_abnormal_nervous_system | 0.93061193 |
87 | MP0001529_abnormal_vocalization | 0.89728480 |
88 | MP0005551_abnormal_eye_electrophysiolog | 0.88698641 |
89 | MP0005167_abnormal_blood-brain_barrier | 0.87158519 |
90 | MP0004185_abnormal_adipocyte_glucose | 0.84140747 |
91 | MP0001502_abnormal_circadian_rhythm | 0.83573772 |
92 | MP0001905_abnormal_dopamine_level | 0.83566539 |
93 | MP0008775_abnormal_heart_ventricle | 0.83154617 |
94 | MP0003631_nervous_system_phenotype | 0.82982646 |
95 | MP0008874_decreased_physiological_sensi | 0.82517008 |
96 | MP0002078_abnormal_glucose_homeostasis | 0.81280832 |
97 | MP0002638_abnormal_pupillary_reflex | 0.79679704 |
98 | MP0002971_abnormal_brown_adipose | 0.78203472 |
99 | MP0000920_abnormal_myelination | 0.77932862 |
100 | MP0006138_congestive_heart_failure | 0.77818690 |
101 | MP0005666_abnormal_adipose_tissue | 0.77461295 |
102 | MP0002069_abnormal_eating/drinking_beha | 0.76162608 |
103 | MP0003195_calcinosis | 0.76017821 |
104 | MP0005085_abnormal_gallbladder_physiolo | 0.75024759 |
105 | MP0006035_abnormal_mitochondrial_morpho | 0.73678331 |
106 | MP0008961_abnormal_basal_metabolism | 0.72986460 |
107 | MP0003656_abnormal_erythrocyte_physiolo | 0.72524112 |
108 | MP0001544_abnormal_cardiovascular_syste | 0.72379068 |
109 | MP0005385_cardiovascular_system_phenoty | 0.72379068 |
110 | MP0005645_abnormal_hypothalamus_physiol | 0.72317507 |
111 | MP0002108_abnormal_muscle_morphology | 0.70915391 |
112 | MP0002090_abnormal_vision | 0.70882418 |
113 | MP0000230_abnormal_systemic_arterial | 0.68476740 |
114 | MP0003045_fibrosis | 0.67765314 |
115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67346586 |
116 | MP0002234_abnormal_pharynx_morphology | 0.66684952 |
117 | MP0003634_abnormal_glial_cell | 0.65925772 |
118 | MP0005253_abnormal_eye_physiology | 0.65087907 |
119 | MP0003787_abnormal_imprinting | 0.64550732 |
120 | MP0000003_abnormal_adipose_tissue | 0.62331310 |
121 | MP0001986_abnormal_taste_sensitivity | 0.61438610 |
122 | MP0005187_abnormal_penis_morphology | 0.60973346 |
123 | MP0004134_abnormal_chest_morphology | 0.59438444 |
124 | MP0001299_abnormal_eye_distance/ | 0.57836212 |
125 | MP0005375_adipose_tissue_phenotype | 0.55514773 |
126 | MP0003828_pulmonary_edema | 0.54100069 |
127 | MP0005171_absent_coat_pigmentation | 0.54016410 |
128 | MP0008872_abnormal_physiological_respon | 0.53661598 |
129 | MP0005332_abnormal_amino_acid | 0.53599901 |
130 | MP0000631_abnormal_neuroendocrine_gland | 0.46160058 |
131 | MP0002102_abnormal_ear_morphology | 0.46020557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 6.11990011 |
2 | Exercise-induced muscle cramps (HP:0003710) | 5.17668566 |
3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.97095509 |
4 | Calf muscle hypertrophy (HP:0008981) | 4.64807651 |
5 | Muscle fiber inclusion bodies (HP:0100299) | 4.62723492 |
6 | * Focal motor seizures (HP:0011153) | 4.60595067 |
7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.35071742 |
8 | Myokymia (HP:0002411) | 4.18164510 |
9 | Nemaline bodies (HP:0003798) | 3.92658883 |
10 | Myoglobinuria (HP:0002913) | 3.80308409 |
11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.68784824 |
12 | Difficulty running (HP:0009046) | 3.68129689 |
13 | Muscle fiber splitting (HP:0003555) | 3.56444222 |
14 | Sudden death (HP:0001699) | 3.54640613 |
15 | Hyporeflexia of lower limbs (HP:0002600) | 3.54543851 |
16 | Myotonia (HP:0002486) | 3.53467094 |
17 | * Focal seizures (HP:0007359) | 3.38932798 |
18 | Abnormality of the calf musculature (HP:0001430) | 3.36321397 |
19 | Atonic seizures (HP:0010819) | 3.32764824 |
20 | Distal arthrogryposis (HP:0005684) | 3.30278544 |
21 | Type 1 muscle fiber predominance (HP:0003803) | 3.29838887 |
22 | * Visual hallucinations (HP:0002367) | 3.21983595 |
23 | EMG: myopathic abnormalities (HP:0003458) | 3.16896781 |
24 | Calcaneovalgus deformity (HP:0001848) | 3.14224254 |
25 | Muscle stiffness (HP:0003552) | 3.10974711 |
26 | Myopathic facies (HP:0002058) | 3.03045782 |
27 | Bundle branch block (HP:0011710) | 2.99762888 |
28 | Abnormal finger flexion creases (HP:0006143) | 2.97773248 |
29 | Distal lower limb muscle weakness (HP:0009053) | 2.87937550 |
30 | Febrile seizures (HP:0002373) | 2.82966601 |
31 | Deformed tarsal bones (HP:0008119) | 2.79960102 |
32 | * Generalized tonic-clonic seizures (HP:0002069) | 2.76271899 |
33 | Round ear (HP:0100830) | 2.74495076 |
34 | * Absence seizures (HP:0002121) | 2.69359014 |
35 | Generalized muscle weakness (HP:0003324) | 2.66217498 |
36 | Rhabdomyolysis (HP:0003201) | 2.66110830 |
37 | Malignant hyperthermia (HP:0002047) | 2.62969748 |
38 | Action tremor (HP:0002345) | 2.61316711 |
39 | Epileptic encephalopathy (HP:0200134) | 2.60698013 |
40 | Dilated cardiomyopathy (HP:0001644) | 2.60036802 |
41 | Pheochromocytoma (HP:0002666) | 2.56259192 |
42 | Ventricular fibrillation (HP:0001663) | 2.54504286 |
43 | Broad-based gait (HP:0002136) | 2.53575768 |
44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52470232 |
45 | * Dialeptic seizures (HP:0011146) | 2.50192201 |
46 | Ankle clonus (HP:0011448) | 2.50143216 |
47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.46003199 |
48 | Lipoatrophy (HP:0100578) | 2.44974636 |
49 | Poor eye contact (HP:0000817) | 2.43108132 |
50 | Syncope (HP:0001279) | 2.40656117 |
51 | Asymmetric septal hypertrophy (HP:0001670) | 2.40654037 |
52 | Progressive cerebellar ataxia (HP:0002073) | 2.39728523 |
53 | Heart block (HP:0012722) | 2.36613113 |
54 | Abnormal social behavior (HP:0012433) | 2.36248608 |
55 | Impaired social interactions (HP:0000735) | 2.36248608 |
56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34303369 |
57 | Supranuclear gaze palsy (HP:0000605) | 2.32747691 |
58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29174082 |
59 | Subaortic stenosis (HP:0001682) | 2.29174082 |
60 | Dysdiadochokinesis (HP:0002075) | 2.28503090 |
61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27902035 |
62 | Anxiety (HP:0000739) | 2.27712299 |
63 | Muscular dystrophy (HP:0003560) | 2.27568293 |
64 | Neuroendocrine neoplasm (HP:0100634) | 2.24001465 |
65 | Urinary urgency (HP:0000012) | 2.23672990 |
66 | Dysmetric saccades (HP:0000641) | 2.23296497 |
67 | Prolonged QT interval (HP:0001657) | 2.23185345 |
68 | Gowers sign (HP:0003391) | 2.22785298 |
69 | Dysmetria (HP:0001310) | 2.21890870 |
70 | Difficulty climbing stairs (HP:0003551) | 2.21865768 |
71 | Atrioventricular block (HP:0001678) | 2.20605091 |
72 | Hyperkalemia (HP:0002153) | 2.18936325 |
73 | Depression (HP:0000716) | 2.18852819 |
74 | Fetal akinesia sequence (HP:0001989) | 2.17049906 |
75 | Postural instability (HP:0002172) | 2.16894733 |
76 | Ventricular arrhythmia (HP:0004308) | 2.16054155 |
77 | Abnormal atrioventricular conduction (HP:0005150) | 2.16005396 |
78 | Weak cry (HP:0001612) | 2.14994083 |
79 | Rimmed vacuoles (HP:0003805) | 2.13495300 |
80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12698071 |
81 | Hyperventilation (HP:0002883) | 2.12301546 |
82 | Increased connective tissue (HP:0009025) | 2.11116284 |
83 | Ulnar deviation of the wrist (HP:0003049) | 2.10566283 |
84 | Ketoacidosis (HP:0001993) | 2.08194350 |
85 | Gout (HP:0001997) | 2.07105680 |
86 | Atrial fibrillation (HP:0005110) | 2.06700157 |
87 | Oligomenorrhea (HP:0000876) | 2.06215753 |
88 | EMG: neuropathic changes (HP:0003445) | 2.04717345 |
89 | Scapular winging (HP:0003691) | 2.03083613 |
90 | Shoulder girdle muscle weakness (HP:0003547) | 2.02432260 |
91 | Abnormal EKG (HP:0003115) | 2.00458834 |
92 | Primary atrial arrhythmia (HP:0001692) | 1.99194664 |
93 | Neck muscle weakness (HP:0000467) | 1.99176210 |
94 | Bulbar palsy (HP:0001283) | 1.97863484 |
95 | Exercise intolerance (HP:0003546) | 1.97003087 |
96 | Gaze-evoked nystagmus (HP:0000640) | 1.96579502 |
97 | Fatigable weakness (HP:0003473) | 1.96378687 |
98 | Abnormality of the neuromuscular junction (HP:0003398) | 1.96378687 |
99 | Absent phalangeal crease (HP:0006109) | 1.96223970 |
100 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95496997 |
101 | Increased muscle lipid content (HP:0009058) | 1.94164145 |
102 | Ventricular tachycardia (HP:0004756) | 1.94017231 |
103 | Central scotoma (HP:0000603) | 1.92072615 |
104 | Limb-girdle muscle atrophy (HP:0003797) | 1.90501376 |
105 | Cerebral inclusion bodies (HP:0100314) | 1.87164725 |
106 | Frequent falls (HP:0002359) | 1.86204907 |
107 | Areflexia of lower limbs (HP:0002522) | 1.86120635 |
108 | Lower limb muscle weakness (HP:0007340) | 1.85425978 |
109 | Left ventricular hypertrophy (HP:0001712) | 1.84969407 |
110 | Abnormality of the corticospinal tract (HP:0002492) | 1.84708080 |
111 | Insidious onset (HP:0003587) | 1.84676655 |
112 | Termporal pattern (HP:0011008) | 1.84676655 |
113 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.83750483 |
114 | Supraventricular tachycardia (HP:0004755) | 1.83702379 |
115 | Lower limb amyotrophy (HP:0007210) | 1.83433843 |
116 | Proximal amyotrophy (HP:0007126) | 1.83341467 |
117 | Waddling gait (HP:0002515) | 1.83189377 |
118 | Progressive inability to walk (HP:0002505) | 1.83184471 |
119 | Hip contracture (HP:0003273) | 1.82419525 |
120 | Neurofibrillary tangles (HP:0002185) | 1.82099071 |
121 | Acute necrotizing encephalopathy (HP:0006965) | 1.81151043 |
122 | Spastic gait (HP:0002064) | 1.80777224 |
123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79226861 |
124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77974599 |
125 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.77417472 |
126 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.77417472 |
127 | Abnormality of the foot musculature (HP:0001436) | 1.77112171 |
128 | Supraventricular arrhythmia (HP:0005115) | 1.76894428 |
129 | Resting tremor (HP:0002322) | 1.76633768 |
130 | Facial diplegia (HP:0001349) | 1.76542283 |
131 | Nonprogressive disorder (HP:0003680) | 1.76175156 |
132 | Ragged-red muscle fibers (HP:0003200) | 1.73325630 |
133 | Slender build (HP:0001533) | 1.72294433 |
134 | Distal lower limb amyotrophy (HP:0008944) | 1.71086631 |
135 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.66592462 |
136 | Long clavicles (HP:0000890) | 1.66445331 |
137 | Mitochondrial inheritance (HP:0001427) | 1.63101414 |
138 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.60874171 |
139 | Progressive macrocephaly (HP:0004481) | 1.59892867 |
140 | Muscle fiber atrophy (HP:0100295) | 1.59737031 |
141 | Progressive muscle weakness (HP:0003323) | 1.58198054 |
142 | Palpitations (HP:0001962) | 1.56026455 |
143 | Acute encephalopathy (HP:0006846) | 1.55407494 |
144 | Type II lissencephaly (HP:0007260) | 1.52619749 |
145 | Increased CSF lactate (HP:0002490) | 1.50163374 |
146 | Steppage gait (HP:0003376) | 1.49794374 |
147 | Foot dorsiflexor weakness (HP:0009027) | 1.48316837 |
148 | Abnormality of the calcaneus (HP:0008364) | 1.47916050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.36343931 |
2 | OBSCN | 3.32258440 |
3 | PHKG1 | 3.27033156 |
4 | PHKG2 | 3.27033156 |
5 | EPHA4 | 3.04592961 |
6 | MAP3K9 | 3.01196197 |
7 | MAP3K4 | 2.51907081 |
8 | MAP2K4 | 2.50943551 |
9 | TTN | 2.25828180 |
10 | PINK1 | 2.22022614 |
11 | MARK1 | 2.14756503 |
12 | KSR2 | 2.12801457 |
13 | PAK6 | 2.06408343 |
14 | NME1 | 1.89086573 |
15 | MAP2K7 | 1.86553563 |
16 | MINK1 | 1.78283556 |
17 | DAPK2 | 1.72389592 |
18 | PDK4 | 1.62058756 |
19 | PDK3 | 1.62058756 |
20 | MAP2K3 | 1.51915559 |
21 | FRK | 1.49163053 |
22 | NTRK1 | 1.42579174 |
23 | GRK5 | 1.41868431 |
24 | NTRK2 | 1.34144755 |
25 | RIPK4 | 1.32154467 |
26 | PRKD3 | 1.30623123 |
27 | NEK1 | 1.25773115 |
28 | ARAF | 1.23539968 |
29 | STK38 | 1.22265846 |
30 | LATS2 | 1.21994580 |
31 | MAPKAPK3 | 1.21457152 |
32 | CAMKK1 | 1.20701850 |
33 | TRPM7 | 1.17825587 |
34 | NUAK1 | 1.16404054 |
35 | MAP3K7 | 1.15440940 |
36 | KSR1 | 1.14838198 |
37 | DMPK | 1.14591406 |
38 | CASK | 1.14005054 |
39 | LMTK2 | 1.13780589 |
40 | CDK5 | 1.10993320 |
41 | ERBB3 | 1.05860623 |
42 | MAP3K2 | 1.01852791 |
43 | VRK2 | 1.01089728 |
44 | MAP3K12 | 1.00847520 |
45 | MAPK12 | 0.98150230 |
46 | PDK2 | 0.97849522 |
47 | SGK494 | 0.97418931 |
48 | SGK223 | 0.97418931 |
49 | CAMK2A | 0.96102489 |
50 | TIE1 | 0.94762874 |
51 | PRKCG | 0.90015528 |
52 | RET | 0.89559291 |
53 | PIK3CA | 0.88029450 |
54 | PLK2 | 0.86222248 |
55 | PRPF4B | 0.85919554 |
56 | MUSK | 0.84293263 |
57 | MAP3K13 | 0.84142817 |
58 | PAK3 | 0.84087253 |
59 | PRKCH | 0.83220044 |
60 | CCNB1 | 0.82621919 |
61 | INSRR | 0.79306735 |
62 | SGK2 | 0.78785820 |
63 | OXSR1 | 0.78563306 |
64 | BCKDK | 0.77292482 |
65 | PDPK1 | 0.76671791 |
66 | MAPKAPK5 | 0.76612016 |
67 | TRIB3 | 0.76072284 |
68 | CAMK4 | 0.75983656 |
69 | PNCK | 0.75899006 |
70 | PDK1 | 0.75667450 |
71 | GRK7 | 0.75600852 |
72 | PIK3CG | 0.75199504 |
73 | CAMK1 | 0.74454649 |
74 | CAMKK2 | 0.74408733 |
75 | STK11 | 0.73963490 |
76 | CAMK2G | 0.72042873 |
77 | SGK1 | 0.71565374 |
78 | SGK3 | 0.71472315 |
79 | PRKAA1 | 0.69777764 |
80 | CAMK2D | 0.68379820 |
81 | MAPK13 | 0.68297908 |
82 | SIK2 | 0.67761972 |
83 | TNIK | 0.66227670 |
84 | CAMK1G | 0.66039086 |
85 | MAP3K6 | 0.65688129 |
86 | MAP3K1 | 0.65217008 |
87 | RAF1 | 0.64640327 |
88 | CDK19 | 0.62016980 |
89 | PKN1 | 0.61696717 |
90 | MAPK11 | 0.61603714 |
91 | WNK1 | 0.60529030 |
92 | TGFBR2 | 0.59515270 |
93 | UHMK1 | 0.58458807 |
94 | FES | 0.57919012 |
95 | CAMK2B | 0.57360700 |
96 | PRKG1 | 0.55991696 |
97 | ADRBK2 | 0.55638845 |
98 | TYRO3 | 0.55026153 |
99 | CSNK1G2 | 0.53521088 |
100 | MARK2 | 0.53484680 |
101 | RPS6KA3 | 0.53067468 |
102 | MAPK4 | 0.52796112 |
103 | GRK1 | 0.52245455 |
104 | BMPR2 | 0.51956146 |
105 | PRKAA2 | 0.51413764 |
106 | AKT3 | 0.51159748 |
107 | MAP2K1 | 0.49976036 |
108 | MAP4K2 | 0.49527836 |
109 | PTK2B | 0.48246548 |
110 | BMPR1B | 0.48070183 |
111 | STK39 | 0.47172837 |
112 | RPS6KB1 | 0.46805684 |
113 | WNK3 | 0.46782549 |
114 | DYRK3 | 0.46708710 |
115 | TAOK1 | 0.46305927 |
116 | MAPK7 | 0.45985560 |
117 | CSNK1G1 | 0.45961550 |
118 | SYK | 0.45948172 |
119 | PRKACA | 0.45383375 |
120 | MAP2K6 | 0.45114922 |
121 | PRKCE | 0.45061608 |
122 | DYRK1A | 0.44947180 |
123 | CDC42BPA | 0.44559903 |
124 | CSNK1G3 | 0.44382857 |
125 | NLK | 0.44136525 |
126 | DYRK1B | 0.43801462 |
127 | TNK2 | 0.42747352 |
128 | VRK1 | 0.42296093 |
129 | DAPK1 | 0.41993015 |
130 | ZAK | 0.41797633 |
131 | MOS | 0.36694003 |
132 | STK38L | 0.33983439 |
133 | LIMK1 | 0.33861506 |
134 | CSNK1D | 0.32661140 |
135 | PRKCQ | 0.31498271 |
136 | ROCK1 | 0.31346415 |
137 | PRKACB | 0.31128585 |
138 | DYRK2 | 0.29365120 |
139 | EEF2K | 0.28998274 |
140 | CSNK1A1L | 0.28029145 |
141 | TAF1 | 0.27828560 |
142 | PRKACG | 0.25024099 |
143 | AKT2 | 0.23234812 |
144 | WNK4 | 0.23228348 |
145 | MAPK10 | 0.20803995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.49699993 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27974675 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.17169181 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.07033048 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01231809 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.93030848 |
7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92478497 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.90718605 |
9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90176126 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88226194 |
11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.85680704 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84043882 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 1.84012415 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81966009 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.76694907 |
16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69505691 |
17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.65773183 |
18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60014257 |
19 | Salivary secretion_Homo sapiens_hsa04970 | 1.59899915 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58140748 |
21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.57589920 |
22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55626702 |
23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.52383121 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50476161 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50290951 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48896564 |
27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46469701 |
28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46308111 |
29 | Renin secretion_Homo sapiens_hsa04924 | 1.44802889 |
30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39896291 |
31 | Taste transduction_Homo sapiens_hsa04742 | 1.37024614 |
32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.29520196 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29367201 |
34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27572263 |
35 | Peroxisome_Homo sapiens_hsa04146 | 1.25258657 |
36 | Long-term depression_Homo sapiens_hsa04730 | 1.24561456 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21341111 |
38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20308350 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19650022 |
40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19507327 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17347618 |
42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14648716 |
43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11310602 |
44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11016861 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09460780 |
46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09183360 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05579989 |
48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04577156 |
49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03601776 |
50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03525907 |
51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03145220 |
52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02792781 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01463830 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99023120 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97667110 |
56 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95950211 |
57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92426126 |
58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91780849 |
59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88982531 |
60 | Gap junction_Homo sapiens_hsa04540 | 0.88792295 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88365599 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87693562 |
63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86466087 |
64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86029204 |
65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82570592 |
66 | Bile secretion_Homo sapiens_hsa04976 | 0.82392492 |
67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82318531 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81713074 |
69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80607455 |
70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80154204 |
71 | Phototransduction_Homo sapiens_hsa04744 | 0.78668812 |
72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77672442 |
73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75720786 |
74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73266682 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72422433 |
76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72371459 |
77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69096257 |
78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67572138 |
79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67528319 |
80 | Melanogenesis_Homo sapiens_hsa04916 | 0.65742020 |
81 | Glioma_Homo sapiens_hsa05214 | 0.64119921 |
82 | RNA degradation_Homo sapiens_hsa03018 | 0.63693794 |
83 | Purine metabolism_Homo sapiens_hsa00230 | 0.62799614 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.62698450 |
85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62627740 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61551329 |
87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61325096 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60801718 |
89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60233034 |
90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60188038 |
91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58657609 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57869061 |
93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57175003 |
94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56803295 |
95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54804122 |
96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54164483 |
97 | Axon guidance_Homo sapiens_hsa04360 | 0.54067293 |
98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53735030 |
99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53579120 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52462747 |
101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52306011 |
102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49387816 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48606142 |
104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48201468 |
105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46328337 |
106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45627744 |
107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45188578 |
108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44831722 |
109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44782801 |
110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44756727 |
111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44600254 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43808579 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.43237868 |
114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42706245 |
115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42408023 |
116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42034978 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41986155 |
118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41217164 |
119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40814733 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40348360 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40152132 |
122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38309087 |
123 | RNA polymerase_Homo sapiens_hsa03020 | 0.34686265 |
124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33255197 |
125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30067299 |
126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29468000 |
127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23380153 |
128 | ABC transporters_Homo sapiens_hsa02010 | 0.23349450 |